Status:
COMPLETED
HIV+ Substance Users Released From Jail
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Conditions:
HIV/AIDS
Substance Use Disorders
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The long-term goal of this project is to improve HIV and substance use outcomes and reduce recidivism for HIV+ substance users released from jail. The overall objective of the proposed R34 project is ...
Detailed Description
Aim 1 Introduction: This first aim will be critical to successful implementation of the CHW-DOORS intervention. Employing a formerly incarcerated CHW to assist individuals leaving prison in order to c...
Eligibility Criteria
Inclusion
- HIV-infected AND
- ≥18 years old AND
- report or have medical records documenting any opioid (illicit or prescription misuse), stimulant (cocaine, ecstasy, or amphetamines), or heavy alcohol use (as determined by the 3-item Alcohol Use Disorders Identification Test (AUDIT-C) within the past 12 months
- Provide two forms of contact information (address, phone number, email, other locator info) AND
- HIV VL \>200 copies/mL within past 90 days OR
- No HIV visit in 6 months OR Self-reported non-adherence to medications
Exclusion
- Unwilling to participate
- Unable to consent
- Does not speak English
- Unwilling to participate
- Unable to consent
- Does not plan to remain in greater Dallas area after release Sentenced to prison or other court-mandated program for ≥6 months
- Does not speak English
- Have an acute medical or psychiatric disorder that would, in the judgment of the PI, make participation difficult or unsafe.
Key Trial Info
Start Date :
May 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03834779
Start Date
May 29 2019
End Date
August 25 2021
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amelia Court, HIV Research Unit
Dallas, Texas, United States, 75235